NMRA Neumora Therapeutics, Inc.
$0.37▼ -6.31%
Healthcare
Other
After hours
$0.41▲ +10.08%
Oct 27, 5:06 PM ET
Volume 1.74M
Avg Volume (10D) 2.07M
Key Metrics & Fundamentals
Market Cap
$69.16M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.32 - 3.65
% vs 50 MA
-57.46%
% vs 200 MA
-79.61%
RSI-14
27.5
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.40
Free Cash Flow
-$39.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$41.26M
COGS
–
Operating Exp
$42.19M
Operating Income
-$42.19M
EBIT
-$42.19M
Pretax Income
-$43.08M
Net Income
-$43.08M
EPS (Diluted)
-0.23
Price & Volume History
Loading chart…
Recent News
Biotech Options Buzz: UTHR, NMRA, EWTX
Schaeffer's Investment Research · Sep 18, 2026 11:46 AM ET
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Simply Wall St. · Sep 4, 2026 6:14 PM ET
Neumora Therapeutics Promotes Joshua Pinto to CEO; Names New Chief Medical Officer
MT Newswires · Aug 14, 2026 8:53 AM ET
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 14, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See NMRA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.